ClinicalTrials.Veeva

Menu

Impact of COVID-19 on Pediatric Dental Practice During First, Second And Third Wave.

Cairo University (CU) logo

Cairo University (CU)

Status

Unknown

Conditions

SARS-CoV2

Study type

Observational

Funder types

Other

Identifiers

NCT04592510
y66cyyg6

Details and patient eligibility

About

Assessment of impact of covid-19 on pediatric dental practice during first, second and third wave among a group of pediatric dentists.

Full description

On the 11th of March, 2020, COVID-19 (SARS-CoV-2) was declared as a pandemic by the World Health Organization. SARS-CoV-2 is an unpredictable virus that is rapidly transmitting from one country to another, and unfortunately as of today, there is no effective medication or vaccine for the disease control. This virus has gone on to cause one of the most rapidly expanding pandemics with over 9 million people being infected worldwide including the pediatric population.

Due to the unique nature of dentistry, most dental procedures generate significant amounts of droplets and aerosols, posing potential risks of infection transmission. Recent studies have demonstrated the role of the oral mucosa in COVID-19 infection, in addition to expressing the ACE2 receptor in salivary glands in the asymptomatic process in infected saliva, thus being one of the main sources of viruses.

Clinical features of COVID-19 in children include fever and cough, but a large proportion of infected children appears to be asymptomatic and may contribute significantly to transmission. Therefore, it can be assumed that, at this stage in the pandemic, all children and their parents/carers are potentially infective with the potential of cross-infection to dental stuff, parents and the public. This has, in theory, an impact on medical and dental procedures that are Aerosol Generating Procedures.

Enrollment

345 estimated patients

Sex

All

Ages

18 to 75 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Egyptian pediatric dentists with at least Master's degree.
  • Work place located in Egypt.

Exclusion criteria

  • Participants who refuse to participate.

Trial contacts and locations

1

Loading...

Central trial contact

Fatma Essam El-Deen

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems